24 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
, (B) any inventory related to the SQZ Clinical Product(s) or SQZ Therapeutic Product(s), including raw materials and other supplies therefor, (C) all … of laboratory and consumable materials and costs of raw materials that are directly attributable to and incurred for any single program. We do not allocate
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
held by the Company, (B) any inventory related to the SQZ Clinical Product(s) or SQZ Therapeutic Product(s), including raw materials and other supplies … the external costs of laboratory and consumable materials and costs of raw materials that are directly attributable to and incurred for any single
8-K
EX-2.1
SQZB
SQZ Biotechnologies Co
22 Dec 23
Entry into a Material Definitive Agreement
5:18pm
of the SQZ Clinical Product(s) or SQZ Therapeutic Product(s), including raw materials and other supplies therefor;
all cells owned or controlled by Seller
10-K
us2j6y2tkf7jtgiq0wpl
18 Mar 21
Annual report
6:31am
424B4
xslx ki7r8ha0b
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
mvq fg5v1
1 Feb 21
Draft registration statement
12:00am
10-Q
gq3bnkt0q5k0jyd
10 Dec 20
Quarterly report
4:46pm
424B4
x7ngycfd9 d9kbmrqss
30 Oct 20
Prospectus supplement with pricing info
4:54pm